Home Cart Sign in  
Chemical Structure| 2059952-75-7 Chemical Structure| 2059952-75-7

Structure of STAT3-IN-1
CAS No.: 2059952-75-7

Chemical Structure| 2059952-75-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

STAT3-IN-1 (compound 7d) is an excellent, selective and orally active STAT3 inhibitor, with IC50 values of 1.82 μM and 2.14 μM in HT29 and MDA-MB 231 cells, respectively. STAT3-IN-1 (compound 7d) induces tumor apoptosis .

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of STAT3-IN-1

CAS No. :2059952-75-7
Formula : C28H29NO6
M.W : 475.53
SMILES Code : COC1=C(C(OC)=CC(/C=C/C(NC2=CC=C(/C=C/C3=CC(OC)=CC(OC)=C3)C=C2)=O)=C1)OC
MDL No. :MFCD32174234
InChI Key :KOZAEBHIXYBHKA-FCXQYMQBSA-N
Pubchem ID :134130166

Safety of STAT3-IN-1

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of STAT3-IN-1

JAK-STAT

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Bone marrow-derived MDSCs 1μM 48 h To evaluate the effect of STAT3-IN-1 on MDSCs-mediated suppression of CD8+ T cell activation and proliferation, results showed that STAT3-IN-1 enhanced CD8+ T cell activation and proliferation. PMC8692894
Gr-1+ cells 1μM 48 h To evaluate the effect of STAT3-IN-1 on GM-CSF-induced ROS and PD-L1 expression in Gr-1+ cells, results showed that STAT3-IN-1 inhibited ROS and PD-L1 expression. PMC8692894
Bone marrow cells 1μM 48 h To evaluate the effect of STAT3-IN-1 on GM-CSF-induced MDSCs expansion, results showed that STAT3-IN-1 inhibited MDSCs expansion. PMC8692894
MEB8-ER cells 5 μM 5 days Inhibition of STAT3 decreases mEB8-ER cell differentiation into neutrophils while promoting differentiation into monocytes/macrophages. PMC10382539
Porcine chondrocytes 5 μM 4 days To investigate the effect of STAT3-IN-1 on CDKN2A expression in porcine chondrocytes, results showed that STAT3-IN-1 reduced CDKN2A expression. PMC11772281

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice MC38 tumor model Intraperitoneal injection 0.2 mg/kg Every 3 days for 21 days To evaluate the effect of Mithramycin A combined with gemcitabine on tumor growth, results showed that the combination treatment significantly suppressed tumor growth and reduced MDSCs infiltration. PMC8692894
Mice 6-week-old male mice Intraperitoneal injection 10 mg/kg Every 2 days for 7 days STAT3-IN-1 treatment reduced the number of neutrophils in the peripheral blood of mice while increasing the number of macrophages. PMC10382539

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.10mL

0.42mL

0.21mL

10.51mL

2.10mL

1.05mL

21.03mL

4.21mL

2.10mL

References

 

Historical Records

Categories